Young breast cancer patients who develop distant metastasis after surgery have better survival outcomes compared with elderly counterparts (Q41280473)

29 September 2017

Young breast cancer patients who develop distant metastasis after surgery have better survival outcomes compared with elderly counterparts (English)

1 reference

29 September 2017

Jingjing Wang

1

1 reference

29 September 2017

Jiayu Wang

2

1 reference

29 September 2017

Qing Li

3

1 reference

29 September 2017

Pin Zhang

4

1 reference

29 September 2017

Peng Yuan

5

1 reference

29 September 2017

Fei Ma

6

1 reference

29 September 2017

Yang Luo

7

1 reference

29 September 2017

Ruigang Cai

8

1 reference

29 September 2017

Ying Fan

9

1 reference

29 September 2017

Shanshan Chen

10

1 reference

29 September 2017

Qiao Li

11

1 reference

29 September 2017

Binghe Xu

12

1 reference

29 September 2017

language of work or name

English

0 references

publication date

11 February 2017

1 reference

29 September 2017

1 reference

29 September 2017

8

1 reference

29 September 2017

27

1 reference

29 September 2017

44851-44859

1 reference

Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

1 October 2017

Breast cancer in China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

1 October 2017

Cancer statistics, 2014

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Comparison of Clinical Features and Treatment Outcome of Breast Cancers in Young and Elderly Chinese Patients

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Treatment of metastatic breast cancer: second line and beyond

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Breast cancer in young women: poor survival despite intensive treatment

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

The clinical efficacy of cytotoxic agents in locally advanced or metastatic breast cancer patients pretreated with an anthracycline and a taxane: a systematic review

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

The global breast cancer burden: variations in epidemiology and survival.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Young age: an independent risk factor for disease-free survival in women with operable breast cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Do very young Korean breast cancer patients have worse outcomes?

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Do young breast cancer patients have worse outcomes?

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5546525

Age as prognostic factor in premenopausal breast carcinoma

19 August 2018

1 reference

12 December 2020

Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer

1 reference

12 December 2020

Breast cancer in young women

1 reference

12 December 2020

Stage 0 to stage III breast cancer in young women

1 reference

12 December 2020

Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients

1 reference

12 December 2020

10.18632/ONCOTARGET.15268

Identifiers

DOI

1 reference

release_5gnmsi5bhnadzdiq5qk2c4qvta

29 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5gnmsi5bhnadzdiq5qk2c4qvta

24 November 2022

mapped directly with Wikidata item

1 reference

29 September 2017

PubMed publication ID

28206957

1 reference